Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christian Marcelli

Showing results (51-60 of 77) with videos related to

Pageof 8
Sort By:
Theranostics|September 18, 2015
Identification of 7 Proteins in Sera of RA Patients with Potential to Predict ETA/MTX Treatment ResponseAntoine Obry, Julie Hardouin, Thierry Lequerré, et al.
Biomolecules|October 23, 2021
Description of Joint Alterations Observed in a Family Carrying p.Asn453Ser <i>COMP</i> Variant: Clinical Phenotypes, In Silico Prediction of Functional Impact on <i>COMP</i> Protein and Stability, and Review of the LiteratureQuitterie Rochoux, Jana Sopkova-de Oliveira Santos, Christian Marcelli, et al.
Annals of the Rheumatic Diseases|December 7, 2010
Mutations of the cystic fibrosis gene in patients with bronchiectasis associated with rheumatoid arthritisXavier Puéchal, Thierry Bienvenu, Emmanuelle Génin, et al.
Joint Bone Spine|December 25, 2016
Soluble vascular endothelial (VE) cadherin and autoantibodies to VE-cadherin in rheumatoid arthritis patients treated with etanercept or adalimumabChristopher Banse, Helena Polena, Barry Stidder, et al.
Clinical and Experimental Rheumatology|October 3, 2024
Evaluation of the nocebo effect after switching from etanercept or adalimumab originator to a biosimilar: a retrospective study of patients with inflammatory rheumatismOuriel Hagege, Pauline Brevet, Baptiste Gerard, et al.
Clinical and Experimental Rheumatology|November 15, 2022
Clinical and ultrasonographic evaluation of the window of opportunity for retreatment with rituximab in rheumatoid arthritis patients from a multicentre real-life studyOlivier Vittecoq, Marie Kozyreff-Meurice, Estelle Houivet, et al.
Rheumatology International|July 27, 2022
The diagnostic challenge of patients with anti-U1-RNP antibodiesInes Elhani, Kathy Khoy, Delphine Mariotte, et al.
Clinical and Experimental Rheumatology|January 24, 2020
Safety of surgery in patients with rheumatoid arthritis treated with tocilizumab: data from the French (REGistry -RoAcTEmra) Regate registryJacques Morel, Marie Locci, Frédéric Banal, et al.
Joint Bone Spine|December 3, 2014
2014 update of recommendations on the prevention and treatment of glucocorticoid-induced osteoporosisKarine Briot, Bernard Cortet, Christian Roux, et al.
Joint Bone Spine|January 25, 2017
Incidence of paradoxical reactions in patients treated with tocilizumab for rheumatoid arthritis: Data from the French registry REGATEWilliam Terreaux, Claire Masson, Jean-Paul Eschard, et al.
Pageof 8

Showing results (51-60 of 77) with videos related to

Sort By:
Pageof 8
Theranostics|September 18, 2015
Identification of 7 Proteins in Sera of RA Patients with Potential to Predict ETA/MTX Treatment ResponseAntoine Obry, Julie Hardouin, Thierry Lequerré, et al.
Biomolecules|October 23, 2021
Description of Joint Alterations Observed in a Family Carrying p.Asn453Ser <i>COMP</i> Variant: Clinical Phenotypes, In Silico Prediction of Functional Impact on <i>COMP</i> Protein and Stability, and Review of the LiteratureQuitterie Rochoux, Jana Sopkova-de Oliveira Santos, Christian Marcelli, et al.
Annals of the Rheumatic Diseases|December 7, 2010
Mutations of the cystic fibrosis gene in patients with bronchiectasis associated with rheumatoid arthritisXavier Puéchal, Thierry Bienvenu, Emmanuelle Génin, et al.
Joint Bone Spine|December 25, 2016
Soluble vascular endothelial (VE) cadherin and autoantibodies to VE-cadherin in rheumatoid arthritis patients treated with etanercept or adalimumabChristopher Banse, Helena Polena, Barry Stidder, et al.
Clinical and Experimental Rheumatology|October 3, 2024
Evaluation of the nocebo effect after switching from etanercept or adalimumab originator to a biosimilar: a retrospective study of patients with inflammatory rheumatismOuriel Hagege, Pauline Brevet, Baptiste Gerard, et al.
Clinical and Experimental Rheumatology|November 15, 2022
Clinical and ultrasonographic evaluation of the window of opportunity for retreatment with rituximab in rheumatoid arthritis patients from a multicentre real-life studyOlivier Vittecoq, Marie Kozyreff-Meurice, Estelle Houivet, et al.
Rheumatology International|July 27, 2022
The diagnostic challenge of patients with anti-U1-RNP antibodiesInes Elhani, Kathy Khoy, Delphine Mariotte, et al.
Clinical and Experimental Rheumatology|January 24, 2020
Safety of surgery in patients with rheumatoid arthritis treated with tocilizumab: data from the French (REGistry -RoAcTEmra) Regate registryJacques Morel, Marie Locci, Frédéric Banal, et al.
Joint Bone Spine|December 3, 2014
2014 update of recommendations on the prevention and treatment of glucocorticoid-induced osteoporosisKarine Briot, Bernard Cortet, Christian Roux, et al.
Joint Bone Spine|January 25, 2017
Incidence of paradoxical reactions in patients treated with tocilizumab for rheumatoid arthritis: Data from the French registry REGATEWilliam Terreaux, Claire Masson, Jean-Paul Eschard, et al.
Pageof 8